Acura Pharmaceuticals (ACUR) Upgraded to Buy by ValuEngine

Acura Pharmaceuticals (ACUR) Upgraded to Buy by ValuEngine


Shares of Acura Pharmaceuticals stock opened at $0.26 on Wednesday. The company has a quick ratio of 0.23, a current ratio of 0.23 and a debt-to-equity ratio of -0.54.



from Biotech News